Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD16 scFv fused to N-terminus of Knob-CH3 domain and the anti-GD2 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Minibody) (MiniB-037). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS